| creatine
in health, medicine and sport
2010
a unique conference to explore the potential health and performance benefits to be gained through creatine supplementation Downing College, University of Cambridge, Cambridge UK 7-10 July 2010
|
 |
WEDNESDAY 7th July
12.00 – 17.00 Registration
17.00 – 17.45 Welcome drink
18.00 – 18.15 Opening address
Mark Tarnopolsky, Conference president
18.15 – 19.10 Cell Motility, Reaction-Diffusion Constraints and
the Origin and Divergence of the Creatine Kinase Enzyme Family.
W. Ross Ellington, Institute of Molecular Biophysics and Department
of Biological Science, Florida State University, Tallahassee,
Florida 32306 USA.
19.30 Welcome buffet and entertainment, cash bar
THURSDAY 8th July
08.30 – 09.25 The creatine kinase system and the pleiotropic
effects of creatine.
Theo Wallimann, formerly at the Institute of Cell Biology, ETH,
Zurich, Switzerland
09.25 – 10.15 Creatine deficiency syndromes, and the importance
of creatine synthesis in the brain.
Olivier Braissant, Inborn Errors of Metabolism, Clinical Chemistry
Laboratory, Centre Hospitalier Universitaire de Lausanne and
University of Lausanne, 1011, Lausanne, Switzerland.
10.15 – 10.45 Morning coffee
10.45 – 11.40 Use of Creatine in the Elderly and Evidence for
Effects on Cognitive Function in Young and Old.
Eric S. Rawson, Bloomsburg University, PA, USA
11.40 – 12.15 The Metabolic Burden of Creatine Synthesis.
John T Brosnan, Department of Biochemistry, Memorial University of
Newfoundland, Canada
12.15 – 12.50 Creatine improves health and survival of mice.
Thomas Klopstock, Friedrich-Baur-Institute, Department of Neurology,
University of Munich, Germany
12.50 – 14.00 Lunch
14.00 – 14.55 Creatine monohydrate as a therapy for muscle
disease and sarcopenia.
Mark Tarnopolsky, Department of Pediatrics and Medicine, McMaster
University, Hamilton, Ontario, Canada
14.55 – 15.45 Neuroprotective Effects of Creatine.
M. Flint Beal, Weill Cornell Medical College, Department of
Neurology and Neuroscience, New York, USA
15.45 – 16.15 Afternoon tea
16.15 – 16.45 Prevention of Complications Related to Traumatic
Brain Injury in Children and Adolescents with Creatine
Administration.
Athanasios Evangeliou, 4th
Department of Pediatrics, Papageorgiou Hospital, Aristotle
University, Thessaloniki, Greece
16.45 – 17.15 Adjunctive Creatine Treatment for Adolescent
Females with Major Depressive Disorder who are Non-Responders to
Fluoxetine (Prozac™): a 31-Phosphorus Magnetic Resonance
Spectroscopy Pilot Study.
Douglas Kondo, The Brain Institute, University of Utah School of
Medicine
17.15 – 17.45 Creatine-creatine kinase system in cancer diagnosis
and the effect of creatine as adjuvant in cancer therapy.
Manju Ray, Department of Biological Chemistry, Indian Association
for the Cultivation of Science, Jadavpur, Kolkata, India.
19.00 Dinner at Downing College for College residents, followed by cash bar, Cambridge at night
FRIDAY 9th July
08.30 – 09.25 The role of phosphorylcreatine in muscle energetics:
more than a reservoir of high-energy phosphates.
Kent Sahlin, GIH, the Swedish School of Sport and Health Sciences,
Åstrands Laboratory, and, Department of Physiology and Pharmacology,
Karolinska Institutet, Stockholm, Sweden.
09.25 – 10.15 Interactions between Creatine and Carbohydrate
Metabolism in Humans.
Paul L Greenhaff, School of Biomedical Sciences, University of
Nottingham Medical School, Queen’s Medical Centre, Nottingham, UK
10.15 – 10.45 Morning coffee
10.45 – 11.15 Efficacy and safety of creatine supplementation
combined with exercise training in type II diabetic patients: a
randomized, double-blind, placebo-controlled, clinical trial.
Bruno Gualano, University of Sao Paulo, Sao Paulo, Brazil.
11.15 – 12.00 Application of creatine and creatine derivatives in
Sport: a systematic review.
Matthew D Vukovich, Dept of Health and Nutrition Sciences, South
Dakota State University, Brookings, USA
12.00 – 12.45 Analysis of the Efficacy and Safety of Novel Forms
of Creatine.
Richard B. Kreider, Exercise & Sport Nutrition Lab, Department of
Health & Kinesiology, Texas A&M University, College Station, Texas,
USA.
12.45 – 14.00 Lunch
14.00 – 14.45 Systems bioenergetics of creatine kinase networks
and mechanisms of clinical effects of phosphocreatine (Neoton).
Valdur A Saks, INSERM U884, Joseph Fourier University, Grenoble,
France and National Institute of Chemical Physics and Biophysics,
Tallinn, Estonia
14.45 – 15.40 Creatine as an antioxidant.
Piero Sestili, Dipartimento di Scienze Biomolecolari – Università
degli Studi di Urbino, Urbino, Italy.
15.40 – 16.00 Afternoon tea
16.00 – 16.55 Studies on the safety of creatine.
Jacques R Poortmans, Free University of Brussels, Belgium
19.00 Drinks and Gala Dinner (ticket only) followed by cash bar
SATURDAY 10th July
08.30 – 08.50 Creatine supplementation reduces increased plasma
homocysteine induced by acute exercise in rats.
Rafael Deminice, Laboratory of Nutrition and Metabolism, University
of Sao Paulo, Brazil.
08.50 – 09.10 Creatine Supplementation Attenuates Human Skeletal
Muscle Damage Induced by Endurance Competition.
Reinaldo Abunasser Bassit, Department of Physiology and Biophysics,
Institute of Biomedical Sciences, University of São Paulo, São
Paulo, Brazil.
09.10 – 09.35 The effect of creatine in extreme sports
1. Creatine supplementation may benefit short duration, high
intensity alpine or slalom skiing.
2. Short duration high intensity sports climbing: increased power
versus weight gain after Creatine supplementation?
Scott M. Graham, Marianne, School of Sport, Faculty of Science,
University of the West of Scotland, UK.
09.35 – 10.05 Supplements and Banned Substance Contamination:
Offering Athletes an Informed Choice.
Dr Catherine Judkins HFL Sport Science, Newmarket, Cambridgeshire,
UK
10.05 – 10.30 A look behind the scenes - Creapure® made by
AlzChem Trostberg GmbH.
Dr Barbara Nieß, AlzChem Trostberg GmbH, Trostberg, Germany
10.30 – 10.55 Morning coffee
10.55 – 11.50 Problems with creatine supplements, manufacturing
pathways as a cause of contaminants, and guarantees to resolve
these.
RJ Maughan, Loughborough University, UK
11.50 – 12.20 Creatine in Health and Medicine
Invited speaker panel
12.20 – 12.50 Creatine
in Sport
Invited speaker panel
12.50 – 13.10 Summing
up and closure of Conference
Mark Tarnopolsky, Conference president
13.10 – 14.00 Lunch
14.00 Two-hour guided tour of Cambridge (delegates must book during the conference) and free evening
Creatine 2010 brings together an
unprecedented group of experts from all corners of the world.
Keynote speakers include:
Professor Flint Beal, Cornell University, USA: Neuroprotective effects of creatine.
Professor Ross Ellington, Florida State University, USA: Cell Motility, Reaction-Diffusion Constraints and the Origin and Divergence of the Creatine Kinase Enzyme Family.
Professor Paul Greenhaff, University of Nottingham, UK: Interactions between creatine and carbohydrate metabolism in humans.
Professor Roger Harris, UK: The PCr-CK system in the maintenance of ATP/ADP homeostasis - implications to peripheral muscle fatigue.
Professor Ron Maughan, University of Loughborough, UK: Problems with creatine supplements, manufacturing pathways as a cause of contaminants, and guarantees to resolve these.
Professor Jacques Poortmans, Universite Libre de Bruxelles, Belgium: Studies on the safety of creatine.
Professor Eric Rawson, Bloomsburg University, USA: Use of creatine in the elderly and evidence for effects on cognitive function in young and old.
Professor Kent Sahlin, GIH, Stockholm, Sweden: The role of phosphorylcreatine in muscle energetics: more than a reservoir of high-energy phosphates
Professor Piero Sestili, University of Urbino, Italy: Creatine as an antioxidant.
Professor Mark Tarnopolsky, McMaster University, Canada: Creatine monohydrate as a therapy for muscle disease and sarcopenia.
Professor Matthew Vukovich, South Dakota State University, USA: Application of creatine and creatine derivatives in sport.
Professor Theo Wallimann, ETH-ZURICH, Switzerland: CK/PCr-system and the pleiotropic actions of Creatine.
Dr Olivier Braissant, Le Centre Hospitalier Universitaire Vaudois de Lausanne, Switzerland: Creatine deficiency syndromes, and the importance of creatine synthesis in the brain.
Dr Barbara Nieß, AlzChem Trostberg GmbH, Germany: A look behind the scenes - Creapure® made by AlzChem Trostberg GmbH.
www.creatineconference2010.org
+44 (0)1223 234193